Myths vs facts: APOA2 and longevity

APOA2 encodes apolipoprotein A-II, a component of HDL. Early studies linked certain APOA2 variants (e.g., rs5082) to altered HDL levels and possibly longevity. However, the evidence is moderate: meta-analyses show inconsistent effects, and the association with longevity is population-dependent (e.g., replicated in some centenarian cohorts but not others). Moreover, APOA2 is often tied to HDL cholesterol, but HDL itself is not a causal longevity marker (Mendelian randomization contradicts a protective effect). A common myth is that APOA2 variants are strong predictors of longevity – this is not supported. Fact: APOA2 has a small, context-dependent effect that can be modulated by diet (e.g., saturated fat intake). Clinical relevance for individuals remains low. Beware of exaggerated claims in direct-to-consumer tests.